CRYAB与肿瘤

doi:10.3760/cma.j.cn371439-20200311-00034

摘要/Abstract

摘要：

αB-晶状体蛋白(CRYAB)具有分子伴侣的作用,可以维持血管内皮生长因子水平,促进肿瘤新生血管的形成。近年来研究发现CRYAB在乳腺癌、肺癌、结直肠癌、膀胱癌等多种肿瘤中异常表达,其可通过促进肿瘤细胞失巢凋亡抵抗,调节基质金属蛋白酶和上皮钙黏着蛋白的分泌以及参与上皮间质转化过程,促进肿瘤的迁移和侵袭。CRYAB在肿瘤细胞中的异常表达与肿瘤分期、淋巴结转移、总生存期以及不良预后显著相关,可作为一种新的肿瘤标志物。

关键词: 肿瘤, 肿瘤转移, 细胞凋亡, CRYAB

Abstract:

AlphaB-crystallin (CRYAB) plays the role of molecular chaperone, it can maintain vascular endothelial growth factor levels and promote tumor neovascularization. Several recent studies indicate that CRYAB is abnormally expressed in various tumors such as breast cancer, lung cancer, colorectal cancer, and bladder cancer. It promotes tumor migration and invasion by promoting the resistance of tumor cells to apoptosis, regulating the secretion of matrix metalloproteinase and cadherin, and participating in the epithelial-mesenchymal transition process. The abnormal expression of CRYAB in tumor cells is significantly related to tumor stage, lymph node metastasis, overall survival and poor prognosis, and can be used as a new tumor marker.

Key words: Neoplasms, Neoplasm metastasis, Apoptosis, CRYAB

戴昂, 孙青. CRYAB与肿瘤[J]. 国际肿瘤学杂志, 2020, 47(6): 351-354.

Dai Ang, Sun Qing. CRYAB and tumors[J]. Journal of International Oncology, 2020, 47(6): 351-354.

参考文献 37

[1]	Haslbeck M, Vierling E. A first line of stress defense: small heat shock proteins and their function in protein homeostasis[J]. J Mol Biol, 2015,427(7):1537-1548. DOI: 10.1016/j.jmb.2015.02.002. doi: 10.1016/j.jmb.2015.02.002 pmid: 25681016
[2]	Qin H, Ni Y, Tong J, et al. Elevated expression of CRYAB predicts unfavorable prognosis in non-small cell lung cancer[J]. Med Oncol, 2014,31(8):142. DOI: 10.1007/s12032-014-0142-1. doi: 10.1007/s12032-014-0142-1 pmid: 25048725
[3]	Tao X, Cheng L, Li Y, et al. Expression of CRYAB with the angiogenesis and poor prognosis for human gastric cancer[J]. Medicine (Baltimore), 2019,98(45):e17799. DOI: 10.1097/MD.0000000000017799. doi: 10.1097/MD.0000000000017799
[4]	朱骏, 冯颖, 张峰, 等. 晶状体蛋白αb在结直肠癌组织中的表达及其临床意义[J]. 中国普外基础与临床杂志, 2015,22(11):1332-1337. DOI: 10.7507/1007-9424.20150348.
[5]	Shi QM, Luo J, Wu K, et al. High level of αB-crystallin contributes to the progression of osteosarcoma[J]. Oncotarget, 2016,7(8):9007-9016. DOI: 10.18632/oncotarget.6928. doi: 10.18632/oncotarget.6928 pmid: 26789112
[6]	Tan L, Sha L, Hou N, et al. High αB-crystallin and p53 co-expression is associated with poor prognosis in ovarian cancer[J]. Biosci Rep, 2019, 39(6). pii: BSR20182407. DOI: 10.1042/BSR20182407. doi: 10.1042/BSR20181147 pmid: 31160489
[7]	Huang Z, Cheng Y, Chiu PM, et al. Tumor suppressor alpha B-crystallin (CRYAB) associates with the cadherin/catenin adherens junction and impairs NPC progression-associated properties[J]. Oncogene, 2012,31(32):3709-3720. DOI: 10.1038/onc.2011.529. doi: 10.1038/onc.2011.529
[8]	Zhang C, Berndt-Paetz M, Neuhaus J. Identification of key biomar-kers in bladder cancer: evidence from a bioinformatics analysis[J]. Diagnostics (Basel), 2020,10(2) pii:E66. DOI: 10.3390/diagnostics10020066.
[9]	Tsang JY, Lai MW, Wong KH, et al. αB-crystallin is a useful marker for triple negative and basal breast cancers[J]. Histopathology, 2012,61(3):378-386. DOI: 10.1111/j.1365-2559.2012.04234.x. doi: 10.1111/j.1365-2559.2012.04234.x
[10]	Rajagopal P, Tse E, Borst AJ, et al. A conserved histidine modulates HSPB5 structure to trigger chaperone activity in response to stress-related acidosis[J]. Elife, 2015,4:e07304. DOI: 10.7554/eLife.07304. doi: 10.7554/eLife.07304
[11]	Bakthisaran R, Akula KK, Tangirala R. Phosphorylation of αB-crystallin: role in stress, aging and patho-physiological conditions[J]. Biochim Biophys Acta, 2016,1860(1 Pt B):167-182. DOI: 10.1016/j.bbagen.2015.09.017. doi: 10.1016/j.bbagen.2015.09.017 pmid: 26415747
[12]	Malin D, Petrovic V, Strekalova E, et al. αB-crystallin: portrait of a malignant chaperone as a cancer therapeutic target[J]. Pharmacol Ther, 2016,160:1-10. DOI: 10.1016/j.pharmthera.2016.01.012. doi: 10.1016/j.pharmthera.2016.01.012 pmid: 26820756
[13]	Yin B, Tang S, Xu J, et al. CRYAB protects cardiomyocytes against heat stress by preventing caspase-mediated apoptosis and reducing F-actin aggregation[J]. Cell Stress Chaperones, 2019,24(1):59-68. DOI: 10.1007/s12192-018-0941-y. doi: 10.1007/s12192-018-0941-y pmid: 30246229
[14]	Malin D, Strekalova E, Petrovic V, et al. ERK-regulated αB-crystallin induction by matrix detachment inhibits anoikis and promotes lung metastasis in vivo[J]. Oncogene, 2015,34(45):5626-5634. DOI: 10.1038/onc.2015.12. doi: 10.1038/onc.2015.12 pmid: 25684139
[15]	van de Schootbrugge C, van Asten F, Nagtegaal ID, et al. αB-crystallin expression is correlated with phospho-ERK1/2 expression in human breast cancer[J]. Int J Biol Markers, 2013,28(4):e365-e370. DOI: 10.5301/JBM.5000032. doi: 10.5301/jbm.5000032 pmid: 23722303
[16]	Malin D, Strekalova E, Petrovic V, et al. αB-crystallin: a novel regulator of breast cancer metastasis to the brain[J]. Clin Cancer Res, 2014,20(1):56-67. DOI: 10.1158/1078-0432.CCR-13-1255. doi: 10.1158/1078-0432.CCR-13-1255 pmid: 24132917
[17]	Chen Z, Ruan Q, Han S, et al. Discovery of structure-based small molecular inhibitor of αB-crystallin against basal-like/triple-negative breast cancer development in vitro and in vivo[J]. Breast Cancer Res Treat, 2014,145(1):45-59. DOI: 10.1007/s10549-014-2940-8. doi: 10.1007/s10549-014-2940-8 pmid: 24710637
[18]	邓亚平, 钟晶敏, 李晶, 等. 乳腺癌中α-晶状体B链蛋白表达的临床病理研究[J]. 现代生物医学进展, 2016,16(29):5663-5666. DOI: 10.13241/j.cnki.pmb.2016.29.016.
[19]	Sultan G, Zubair S, Tayubi IA, et al. Towards the early detection of ductal carcinoma (a common type of breast cancer) using biomarkers linked to the PPAR(γ) signaling pathway[J]. Bioinformation, 2019,15(11):799-805. DOI: 10.6026/97320630015799. doi: 10.6026/97320630015799 pmid: 31902979
[20]	Guo Z, Song J, Hao J, et al. M2 macrophages promote NSCLC metastasis by upregulating CRYAB[J]. Cell Death Dis, 2019,10(6):377. DOI: 10.1038/s41419-019-1618-x. doi: 10.1038/s41419-019-1618-x pmid: 31097690
[21]	Chen D, Cao G, Qiao C, et al. Alpha B-crystallin promotes the invasion and metastasis of gastric cancer via NF-κB-induced epithelial-mesenchymal transition[J]. J Cell Mol Med, 2018,22(6):3215-3222. DOI: 10.1111/jcmm.13602. doi: 10.1111/jcmm.13602 pmid: 29566309
[22]	Shi C, Yang X, Bu X, et al. Alpha B-crystallin promotes the invasion and metastasis of colorectal cancer via epithelial-mesenchymal transition[J]. Biochem Biophys Res Commun, 2017,489(4):369-374. DOI: 10.1016/j.bbrc.2017.05.070. doi: 10.1016/j.bbrc.2017.05.070 pmid: 28506831
[23]	Li Q, Wang Y, Lai Y, et al. HspB5 correlates with poor prognosis in colorectal cancer and prompts epithelial-mesenchymal transition through ERK signaling[J]. PLoS One, 2017,12(8):e0182588. DOI: 10.1371/journal.pone.0182588. doi: 10.1371/journal.pone.0182588 pmid: 28796798
[24]	Zhang L, Zhang L, Xia X, et al. Krüppel-like factor 4 promotes human osteosarcoma growth and metastasis via regulating CRYAB expression[J]. Oncotarget, 2016,7(21):30990-31000. DOI: 10.18632/oncotarget.8824. doi: 10.18632/oncotarget.8824 pmid: 27105535
[25]	Wang SN, Luo S, Liu C, et al. miR-491 inhibits osteosarcoma lung metastasis and chemoresistance by targeting αB-crystallin[J]. Mol Ther, 2017,25(9):2140-2149. DOI: 10.1016/j.ymthe.2017.05.018. doi: 10.1016/j.ymthe.2017.05.018 pmid: 28648665
[26]	Yilmaz M, Karatas OF, Yuceturk B, et al. Alpha-B-crystallin expression in human laryngeal squamous cell carcinoma tissues[J]. Head Neck, 2015,37(9):1344-1348. DOI: 10.1002/hed.23746. doi: 10.1002/hed.23746 pmid: 24817638
[27]	Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019[J]. CA Cancer J Clin, 2019,69(1):7-34. DOI: 10.3322/caac.21551. doi: 10.3322/caac.21551 pmid: 30620402
[28]	张文君, 刘斌, 令狐华. 晶状体蛋白αB对卵巢癌细胞恶性行为的影响[J]. 第三军医大学学报, 2017,39(3):223-228. DOI: 10.16016/j.1000-5404.201609030.
[29]	李华, 刘兴元, 王玲, 等. 发病年龄对子宫内膜癌患者预后的影响分析[J]. 癌症进展, 2016,14(07):696-698. DOI: 10.11877/j.issn.1672-1535.2016.14.07.27.
[30]	Wyciszkiewicz A, Kalinowska-Łyszczarz A, Nowakowski B, et al. Expression of small heat shock proteins in exosomes from patients with gynecologic cancers[J]. Sci Rep, 2019,9(1):9817. DOI: 10.1038/s41598-019-46221-9. doi: 10.1038/s41598-019-46221-9 pmid: 31285463
[31]	高瑾, 李丽, 赵娟, 等. 慢病毒介导的αB-晶状体蛋白基因沉默对子宫内膜癌ISK细胞增殖和迁移能力的影响[J]. 现代肿瘤医学, 2017,25(18):2865-2869. DOI: 10.3969/j.issn.1672-4992.2017.18.002.
[32]	Kori M, Yalcin Arga K. Potential biomarkers and therapeutic targets in cervical cancer: insights from the meta-analysis of transcriptomics data within network biomedicine perspective[J]. PLoS One, 2018,13(7):e0200717. DOI: 10.1371/journal.pone.0200717. doi: 10.1371/journal.pone.0200717 pmid: 30020984
[33]	Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018,68(6):394-424. DOI: 10.3322/caac.21492. doi: 10.3322/caac.21492 pmid: 30207593
[34]	Ho PY, Chueh SC, Chiou SH, et al. ΑB-crystallin in clear cell renal cell carcinoma: tumor progression and prognostic significance[J]. Urol Oncol, 2013,31(7):1367-1377. DOI: 10.1016/j.urolonc.2012.01.015. doi: 10.1016/j.urolonc.2012.01.015 pmid: 22417627
[35]	Wang Z, Wang L, Huang ZX, et al. Contrast functions of αA- and αB-crystallins in cancer development[J]. Curr Mol Med, 2017,16(10):914-922. DOI: 10.2174/1566524016666161223110508. doi: 10.2174/1566524016666161223110508 pmid: 28017134
[36]	Ruan H, Li Y, Wang X, et al. CRYAB inhibits migration and invasion of bladder cancer cells through the PI3K/AKT and ERK pathways[J]. Jpn J Clin Oncol, 2020,50(3):254-260. DOI: 10.1093/jjco/hyz172. doi: 10.1093/jjco/hyz172 pmid: 31829429
[37]	Valcarcel-Jimenez L, Macchia A, Martín-Martín N, et al. Integrative analysis of transcriptomics and clinical data uncovers the tumor-suppressive activity of MITF in prostate cancer[J]. Cell Death Dis, 2018,9(10):1041. DOI: 10.1038/s41419-018-1096-6. doi: 10.1038/s41419-018-1096-6 pmid: 30310055

CRYAB与肿瘤

CRYAB and tumors

RichHTML

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献 37

相关文章 15

编辑推荐

Metrics

本文评价

[1]	刘娜, 寇介丽, 杨枫, 刘桃桃, 李丹萍, 韩君蕊, 杨立洲. 血清miR-106b-5p、miR-760联合低剂量螺旋CT诊断早期肺癌的临床价值[J]. 国际肿瘤学杂志, 2024, 51(6): 321-325.
[2]	杨蜜, 别俊, 张加勇, 邓佳秀, 唐组阁, 卢俊. 局部晚期可切除食管癌新辅助治疗疗效及预后分析[J]. 国际肿瘤学杂志, 2024, 51(6): 332-337.
[3]	袁健, 黄燕华. Hp-IgG抗体联合血清DKK1、sB7-H3对早期胃癌的诊断价值[J]. 国际肿瘤学杂志, 2024, 51(6): 338-343.
[4]	陈红健, 张素青. 血清miR-24-3p、H2AFX与肝癌患者临床病理特征及术后复发的关系研究[J]. 国际肿瘤学杂志, 2024, 51(6): 344-349.
[5]	郭泽浩, 张俊旺. PFDN及其亚基在肿瘤发生发展中的作用[J]. 国际肿瘤学杂志, 2024, 51(6): 350-353.
[6]	张百红, 岳红云. 新作用机制的抗肿瘤药物进展[J]. 国际肿瘤学杂志, 2024, 51(6): 354-358.
[7]	许凤琳, 吴刚. EBV在鼻咽癌肿瘤免疫微环境和免疫治疗中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 359-363.
[8]	王盈, 刘楠, 郭兵. 抗体药物偶联物在转移性乳腺癌治疗中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 364-369.
[9]	张蕊, 褚衍六. 基于FIT与肠道菌群的结直肠癌风险评估模型的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 370-375.
[10]	高凡, 王萍, 杜超, 褚衍六. 肠道菌群与结直肠癌非手术治疗的相关研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 376-381.
[11]	王丽, 刘志华, 杨伟洪, 蒋凤莲, 李全泳, 宋浩杰, 鞠文东. ROS1突变肺腺鳞癌合并脑梗死为主要表现的Trousseau综合征1例[J]. 国际肿瘤学杂志, 2024, 51(6): 382-384.
[12]	刘静, 刘芹, 黄梅. 基于SMOTE算法的食管癌放化疗患者肺部感染的预后模型构建[J]. 国际肿瘤学杂志, 2024, 51(5): 267-273.
[13]	杨琳, 路宁, 温华, 张明鑫, 朱琳. 炎症负荷指数与胃癌临床关系研究[J]. 国际肿瘤学杂志, 2024, 51(5): 274-279.
[14]	王俊毅, 洪楷彬, 纪荣佳, 陈大朝. 癌结节对结直肠癌根治性切除术后肝转移的影响[J]. 国际肿瘤学杂志, 2024, 51(5): 280-285.
[15]	张宁宁, 杨哲, 檀丽梅, 李振宁, 王迪, 魏永志. 宫颈细胞DNA倍体分析联合B7-H4和PKCδ对宫颈癌的诊断价值[J]. 国际肿瘤学杂志, 2024, 51(5): 286-291.